• 한국식품위생안전성학회지
• /
• 제12권2호
• /
• pp.141-152
• /
• 1997

This study was performed to investigate the toxic effect of pyrrolizidine alkaloids from symphytum officinale i n rat. For this experiment, 120 male and female rats of Sprague-Dawley strain were used. The experimental groups were divided into five: Group CM and CF served as normal control with its gender. Group EM1 and EF1 were fed a 1% Symphytum officinal extract diet for 8 weeks. Group EM2 and EF2 fed a diet containing 2% extract diet. 4% extract diet into group EM3 and EF3 and 8% extract diet into group EM4 and EF4 were given. The results were as follows: 1. The major alkaloids of Symphytum officinale extract were symphytine, echmidine, and lasiocarpine. The amounts of total alkaloid were 168 $\mu\textrm{g}$ PAs/$m\ell$ extract. And contents of Pas in leaves were 0.05% wt.. 2. Total serum bilirubin concentrations increased significantly in group EM2, EM3, and EM4. Group EF1, EF2, EF3, and EF4 showed statistical significance for the group CF (p<0.05). 3. Aspartate transaminase activities were increased significantly in group EM3 and EM4 (p<0.05). Aspartate transaminase activities of EF1, EF2, EF3, and EF4 showed statistical significance for the group CF (p<0.05). 4. Alanine transaminase activities increased significantly in group EM3, EM4 (p<0.05). Alanine transaminase activities of EF1, EF2, EF3, and EF4 showed statistical significance for the group CF (p<0.05). 5. Alkaline phosphatase activities increased significantly in group EM2, EM3, and EM4 (p<0.05). Alkaline phosphatase activities of EF1, FE@, EF3, and EF4 showed statistical sigmificance for the group CF (p<0.05). 6. istopathological analysis of liver specimens from group EM3 and EM4 showed focal necrosis, periportal necrosis and apoptpsis. Hepatocytes obtained from group EM2 showed fatty change and hydropic degeneration in group EM3 and EM4. Chromatolysis and chromatin margination was shown in group EF2 and EF3. With the above results, it was demonstrated that the Symphytum officinal extract could induce functional change of liver, and histopathological change of liver in rats fed a diet containing extract. In conclusion, because of the risk of intoxication or adverse effect, the composition, dosage and mode of administration of herbal products should be monitored strictly. And this study serves as a reminder that herbal as well as orthodox medications may have serious side effects.

• Journal of Plant Biology
• /
• 제37권3호
• /
• pp.325-332
• /
• 1994

The effects of polyamines on the activities of elongation factors EF-1 and EF-2, phenylalanyl-tRNA synthetase, and tRNA were investigated. The activities of EF-1 and EF-2 were mostly stimulated by spermidine among three kinds of polyamines. The activities of EF-1 and EF-2 were investigated in the presence of spermidine by 230 and 181%, respectively. The activity of phenylalanyl-tRNA synthetase was slightly increased in the presence of polyamines. The effect of spermine on the synthetase was higher than that of the other polyamines. The tRNA activity in the presence fo polyamines was increased by 206% with spermidine, by 144% with spermine, and by 114% with putrescine. According to these results, it is concluded that polyamines in higher plants stimulate the protein biosynthesis by promoting the activities of elongation factors EF-1 and EF-2, aminoacyl-tRNA synthetases, and tRNAs, but the effects of polyamines on the various components for protein biosynthesis are different in according to the kind of polyamines.

• 대한기계학회논문집B
• /
• 제38권9호
• /
• pp.763-771
• /
• 2014

본 연구는 에멀젼연료($diesel/H_2O_2$)의 분무거동특성에 관한 기초 연구로서 에멀젼연료를 제조하여 분무 거동특성에 영향을 주는 연료의 물성치(점도, 표면장력, 밀도)와 연료액적 증발특성을 조사하였다. 또한 에멀젼연료와 디젤연료의 거시적 분무거동특성인 분무선단도달거리, 분무각을 비교 분석하였다. 에멀젼연료의 교반 조건은 디젤 연료와 계면활성제 span 80, tween 80을 각각 9:1로 혼합한 유화제를 제작하여 사용 하였으며 과산화수소의 혼합비율은[EF(Emulsified Fuel)2, EF12, EF22, EF32, EF42, EF52, EF62, EF72, EF82, EF92]로 설정하였고, 분사압력은 400bar, 600bar, 800bar 및 1000bar로 설정하였다. 본 연구의 결과로서 연료의 점도는 과산화수소의 혼합비율이 증가할수록(EF52까지) 점도가 증가하나, 그 이후부터는 점도가 낮아져 기존의 디젤연료와 같은 점도를 가지게 된다. 이는 디젤의 혼합비율이 큰 EF52까지는 교반 시 수중유형(Water in Oil)이 생성되나 과산화수소의 혼합비율이 큰(EF52 이상) 에멀젼연료에서는 유중수형(Oil in Water)이 생성되기 때문이다. 또한 혼합비 변화에 따른 분무거동의 특성(분무선단도달거리, 분무각)의 변화는 크지 않았다.

• 핵의학기술
• /
• 제13권3호
• /
• pp.3-9
• /
• 2009

목적 : 심근관류 스펙트 검사 시 부하로 인한 일시적인 심근 기절, 가역적 관류결손 등이 좌심실 구혈률에 영향을 준다는 사실은 익히 알려져 있다. 이러한 이유로 부하기/휴식기검사시 게이트법의 적용이 권고되고 있으며 99m-Tc을 이용하여 부하기/휴식기 좌심실 구혈률의 상관관계에 대한 연구가 여러 차례 이루어졌다. 본 연구의 목적은 99m-Tc 대신 Tl-201을 이용한 심근관류 스펙트에서 부하기와 휴식기 좌심실 구혈률의 상관관계를 규명하고 좌심실 구혈률의 변동의 예측가능한 지표를 정의하는 것이다. 실험재료 및 방법 : 2008년 6월부터 2009년 2월까지 본원에서 $^{201}Tl$ 게이트 심근관류 SPECT 검사를 시행한 환자 중 성인 144명(남:여=87:57, 평균나이 $62{\pm}10$세)의 환자를 대상으로 연구 분석하였다. 데이터 분석에는 QGS (Quantitative gated SPECT) 소프트웨어를 이용하였고, 자동화된 방식으로 수축기말 용적(End-systolic volume, ESV), 확장기말 용적(End-diastolic volume, EDV), EF를 구하였다. 본 연구에서는 부하기/휴식기의 EF값, EDV와 ESV의 크기, 심근관류결손의 가역성 여부를 기준으로 EF값의 상관관계를 paired t- test와 Bland-Altman 분석을 이용하여 비교 분석 하였다. 결과 : 부하기와 휴식기 EF값의 대응분포는 높은 상관관계(r=0.92)를 나타냈으며, 이들간의 EF값의 차이는 통계적으로 유의하지 않았다(p=0.11). Bland-Altman 분석 결과 부하기와 휴식기 EF값의 차이(${\Delta}EF$)는 평균 0.52% (95% 신뢰구간, -1.17~0.12%)로 나타났다. 평균 ${\Delta}EF$와 부하기와 휴식기 EF값의 차이가 없을 것이라는 가설(${\Delta}EF$=0)과의 차이는 통계적으로 유의한 차이를 보이지 않았다(p=0.10). 부하기와 휴식기 EDV와 ESV에 따른 ${\Delta}EF$의 상관관계는 휴식기 ESV가 28mL 미만(p<0.05)일 때를 제외하고 모두 통계적으로 의미있는 차이가 없었고, 관류결손의 가역성 여부에 따른 ${\Delta}EF$의 상관관계에서는 가역성 관류결손을 가진 환자에게서 ${\Delta}EF$의 유의한 차이가 나타났다(p<0.05). 부하기와 휴식기 EF값에 따른 ${\Delta}EF$는 부하기 EF가 55% 미만일 경우에 유의한 차이가 나타났다(p<0.05). 결론 : $^{99m}Tc$-MIBI을 이용한 연구 결과와 마찬가지로 휴식기와 부하기 EF값의 변동에는 대체로 유의한 차이가 없었다. 다만 부하기 EF값이 55% 미만일 경우, 휴식기 ESV가 28 mL 미만일 경우, 가역성 관류결손을 가진 환자의 경우에 ${\Delta}EF$에 유의한 차이가 발생하는 것을 확인하였다. 그러므로 본 연구의 결과를 충분히 고려하여, 게이트 심근관류 SPECT 검사시 심기능이 저하된 환자나 가역성 관류결손을 가진 환자에게서 ${\Delta}EF$의 유의한 차이 발생을 사전에 인지 가능한 유용한 지표로 활용할 수 있을 것으로 기대한다.

• 대한기계학회논문집B
• /
• 제39권3호
• /
• pp.237-243
• /
• 2015

본 논문은 에멀젼연료(Diesel/$H_2O_2$)에 있어 과산화수소의 혼합비가 혼합연료 액적증발 및 분무거동 특성에 미치는 영향을 연구하였다. 연료혼합을 위한 계면활성제는 span 80, tween 80을 9:1로 혼합하여 에멀젼연료 총 부피의 3%로 고정 혼합하였다. 또한 과산화수소의 혼합비율은 계면활성제의 혼합비를 고려하여 EF (Emulsified Fuel)0, EF2, EF12, EF22, EF32 및 EF42로 설정하였다. 에멀젼연료 액적의 증발특성을 관찰하기 위해 가열판에 액적 방울을 투하시켜 액적이 증발하는 현상을 산란광 및 쉴리렌기법을 통하여 촬영하였다. 또한 혼합비 변화에 따른 혼합연료의 분무거동특성을 해석하기 위하여 혼합연료 EF0~EF22를 선택하여 $150^{\circ}C$로 유지된 정적용기에서 증발자유분무 거동해석 실험을 실시하였다. 그 결과 과산화수소의 혼합비율이 EF0보다 높은 EF22 에멀젼연료의 자유분무성장이 연료 속에 혼합된 과산화수소의 증발촉진으로 인하여 보다 신속하였다.

• 대한한의학방제학회지
• /
• 제19권1호
• /
• pp.219-231
• /
• 2011

Objectives : This study was designed to determine the effects of the GGEx18 ethyl acetate fraction(EF) on body weight gain, feeding efficiency ratio, and obesity-related factors in plasma as well as histology of liver and adipose tissues using high fat diet-fed male C57BL/6N obese mice. Methods : 8 weeks old, high fat diet-fed obese male mice were divided into 5 groups: C57BL/6N normal, control, EF(1), EF(2) and EF(3). After mice were treated with EF for 9 weeks, we measured body weight gain, food intake, feeding efficiency ratio, fat weight, plasma leptin and lipid levels. We also analysed histology of liver and adipose tissues on high fat diet-fed male C57BL/6N obese mice. Results : Compared with control, EF-treated mice had significantly lower body weight gain and feeding efficiency ratio. Consistent with the effects on body weight gain, EF significantly decreased the adipose tissue weight compared with control. Consistent with the effects on feeding efficiency ratio, EF significantly decreased plasma leptin concentrations compared with control. EF reduced the size of adipocytes as well as hepatic lipid accumulation compared with control. EF seems to be safe since not only the plasma levels of ALT and AST are within the normal range, but also EF did not show any toxic effects on organs. EF(3) was most effective among EF(1), EF(2), and EF(3) at doses of 25, 50, and 100 mg/kg, respectively. Conclusions : These results demonstrate that EF effectively reduces body weight gain, feeding efficiency ratio in high fat diet-fed obese mice, leading to the modulation of obesity. In addition, EF decreases the size of adipocytes and improves plasma lipids and controls hepatic lipid accumulation, suggesting that EF may act as a therapeutic agent for obesity.

• Toxicological Research
• /
• 제34권1호
• /
• pp.55-63
• /
• 2018

As a part of general toxicity studies of Enterococcus Faecalis 2001 (EF 2001) prepared using heat-treatment bacillus mort body EF 2001 in mice, this study examined the toxicity of EF 2001 in single and repeated administrations following the previous report in order to apply this product to preventive medicine. The safety of oral ingestion of EF 2001 was examined in 6-week-old male and female ICR mice with 1,000 mg/kg, 3,000 mg/kg and 5,000 mg/kg body weight/day administrated by gavage of the maximum acceptable dose of EF 2001. The study was conducted using distilled water as a control following the methods for general toxicity studies described in the "Guidelines for Non-clinical Studies of Pharmaceutical Products 2002". As a control, 1) observation of general conditions, 2) measurement of body weight, 3) determination of food consumption, 4) determination of water consumption, 5) blood test and urinalysis and 6) pathological examination were performed for the administration of EF 2001. Mice received EF 2001 for 13 weeks and results were compared with those of the control group that received distilled water. The results of the above examinations revealed no significant differences between control and EF 2001 groups for both males and females. Thus, no notable toxicity was confirmed with single and repeated oral administrations of EF 2001. Oral administration in the above doses did not result in abnormal symptoms or death during the observation period. No abnormalities in blood cell count or organ weights were seen. Without any evidence of toxicity to cells and organs, EF 2001 is speculated to not adversely affect living organisms. The 50% lethal dose of EF 2001 with oral administration in mice is estimated to be greater than 5,000 mg/kg body weight/day for both male and female mice. Therefore, $LD_{50}$ value for animals was 5,000 mg/kg or more.

• Asian-Australasian Journal of Animal Sciences
• /
• 제19권3호
• /
• pp.406-411
• /
• 2006

The objective of this study was to investigate the effects of feeding probiotic (Enterococcus faecium SF68, EF) on growth performance, nutrient digestibility, blood characteristics and faecal noxious gas content in finishing pigs. A total of eighty [($Landrace{\times}Yorkshire$)${\times}Duroc$] pigs with an initial BW of $50.47{\pm}2.13kg$ were used in this 8-week experiment. Pigs were allotted to four treatments (4 replicates per treatment and 5 pigs per pen) according to a randomized complete block design. Dietary treatments were: 1) CON (control; basal diet), 2) CTC (control diet+0.1% antibiotic, chlortetracycline), 3) EF1 (control diet+0.1% probiotic, EF) and 4) EF2 (control diet+0.2% probiotic, EF). During weeks 0-4, ADG was not affected by the addition of antibiotic or EF (p>0.05). In weeks 4-8, ADG tended to increase in CTC and EF treatments compared to CON treatment (p<0.10). ADFI and gain/feed were not affected in each 4-week period and the entire experimental period (p>0.05). Digestibilities of DM and N were higher in EF supplemented treatments than in CON and CTC treatments (p<0.05). Blood characteristics of WBC, RBC and lymphocyte were not affected in pigs given diets containing EF (p>0.05). Supplementation of EF in the diet decreased faecal ammonia nitrogen ($NH_3$-N) and hydrogen sulphide ($H_2S$) concentrations (p<0.05). Faecal acetic acid concentration tended to decrease (p<0.10) while propionic acid and butyric acid concentrations were significantly lower on diets with EF supplementation than on the diet containing antibiotic (p<0.05). In conclusion, dietary supplementation of EF can increase nutrient digestibility and decrease faecal $NH_3$-N, $H_2S$ and volatile fatty acid (VFA) concentrations in finishing pigs.

• Journal of Animal Science and Technology
• /
• 제66권1호
• /
• pp.204-218
• /
• 2024

Elsholtzia fruticosa (EF) is present in tropical regions throughout South Asian countries as well as the Himalayas. Although it has been used as a traditional medicine to treat digestive, respiratory, and inflammatory issues, its effect on preadipocyte differentiation is unknown. In this study, we examined the effects of a methanol extract prepared from EF on the differentiation of 3T3-L1 preadipocytes. Cell differentiation was assessed by microscopic observation and oil-red O staining. The expression of adipogenic and lipogenic genes, including PPARγ and C/EBPα, was measured by western blot analysis and quantitative real-time polymerase chain reaction (qRT-PCR), to provide insight into adipogenesis and lipogenesis mechanisms. The results indicated that EF promotes the differentiation of 3T3-L1 preadipocytes, with elevated lipid accumulation occurring in a concentration-dependent manner without apparent cytotoxicity. EF enhances the expression of adipogenic and lipogenic genes, including PPARγ, FABP4, adiponectin, and FAS, at the mRNA and protein levels. The effect of EF was more pronounced during the early and middle stages of 3T3-L1 cell differentiation. Treatment with EF decreased C/EBP homologous protein (CHOP) mRNA and protein levels, while increasing C/EBPα and PPARγ expression. Treatment with EF resulted in the upregulation of cyclin E and CDK2 gene expression within 24 h, followed by a decrease at 48 h, demonstrating the early-stage impact of EF. A concomitant increase in cyclin-D1 levels was observed compared with untreated cells, indicating that EF modulates lipogenic and adipogenic genes through intricate mechanisms involving CHOP and cell cycle pathways. In summary, EF induces the differentiation of 3T3-L1 preadipocytes by increasing the expression of adipogenic and lipogenic genes, possibly through CHOP and cell cycle-dependent mechanisms.

• BMB Reports
• /
• 제45권4호
• /
• pp.227-232
• /
• 2012

In vertebrates, there are two variants of eukaryotic peptide elongation factor 1A (eEF1A; formerly eEF-$1{\alpha}$), eEF1A1 and eEF1A2, which have three well-conserved domains ($D_I$, $D_{II}$, and $D_{III}$). In neurons, eEF1A1 is the embryonic type, which is expressed during embryonic development as well as the first two postnatal weeks. In the present study, EGFP-tagged eEF1A1 truncates were expressed in cortical neurons isolated from rat embryo (E18-19). Live cell images of transfected neurons showed that $D_{III}$-containing EGFP-fusion proteins (EGFP-$D_{III}$, -$D_{II-III}$, -$D_{I-III}$) formed clusters that were confined within somatodendritic domains, while $D_{III}$-missing ones (EGFP-$D_I$, -$D_{II}$, -$D_{I-II}$) and control EGFP were homogeneously dispersed throughout the neuron including axons. In dendrites, EGFP-$D_{III}$ was targeted to the heads of spine- and filopodia-like protrusions, where it was colocalized with $SynGAP{\alpha}$, a postsynaptic marker. Our data indicate that $D_{III}$ of eEF1A1 mediates formation of clusters and localization to spines.